WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding ...
Adam Kovalčík showed off a poster about his research at the Regeneron International Science and Engineering Fair in Columbus, Ohio.Chris Ayers Photography/Licensed by Society for Science When Adam ...
Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming ...
Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this year ...
A single type of chemical structure that shows up again and again in modern medicine is the amide bond that links a carbonyl group (C=O) to a nitrogen atom. They're so ubiquitous that 117 of the top ...
Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...
The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results